Medication Comparison
Compare available treatments and medications in development for hypoparathyroidism. This page helps you understand your options so you can have informed conversations with your doctor.
Not Medical Advice. This information is for educational purposes only. Treatment decisions should always be made with your endocrinologist or healthcare provider. Bari Vapnek is a patient advocate, not a medical professional.
Available Treatments
These treatments are currently available (in some countries) for managing hypoparathyroidism. Use the checkboxes to select treatments for comparison, or tap any row to see full details.
| Select | Treatment | Route |
|---|---|---|
Standard of Care / Conventional Therapy Active Vitamin D + Calcium | Oral (frequent daily dosing) | |
Teriparatide (Forteo) Short-Acting PTH Replacement | 1–4 daily injections or continuous pump delivery | |
Palopegteriparatide (Yorvipath) Long-Acting PTH Replacement | Once daily injection |
Standard of Care / Conventional Therapy
Active Vitamin D + Calcium
Tap to see full details
Teriparatide (Forteo)
Short-Acting PTH Replacement
Tap to see full details
Palopegteriparatide (Yorvipath)
Long-Acting PTH Replacement
Tap to see full details
Treatments in Development
These treatments are currently being studied in clinical trials or pre-clinical development. They are not yet available for patients to use. Use the checkboxes to add them to your comparison, or tap any row to learn more.
| Select | Treatment | Route | Phase |
|---|---|---|---|
| Encaleret | Oral | ADH1: Phase 3 complete | |
| Eneboparatide | Daily injection | Phase 3 in progress | |
| Canvuparatide | Weekly injection | Phase 3 planned | |
| EB612 | Oral | Phase 2 planned | |
| SEP786 | Oral | Phase 1 completed | |
| XH02 | Injection | Pre-clinical development | |
| Gubra PTH | Injection | Pre-clinical development |
Encaleret
BridgeBio
Tap to see full details
Eneboparatide
AstraZeneca
Tap to see full details
Canvuparatide
MBX Biosciences
Tap to see full details
EB612
Entera Bio
Tap to see full details
SEP786
Septerna
Tap to see full details
XH02
PUMCH
Tap to see full details
Gubra PTH
Camrus & Gubra
Tap to see full details
A Note About This Page
This comparison is designed to help patients understand the landscape of hypoparathyroidism treatments. The information is based on publicly available data and may not reflect the most recent developments. Treatment decisions are personal and should always be made in consultation with your endocrinologist or healthcare team. Different treatments work differently for different patients — what matters most is finding what works best for you.
Have Questions About Your Treatment?
Talk to your doctor about which treatment option may be right for you. You can also ask Bari about her personal experience.